Tilton John
Chief Commercial Officer at Biohaven Pharmaceutical Holding Co Ltd.
- Sold, on record
- $5.3M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Jun 10, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Biohaven Pharmaceutical Holding Co Ltd.Chief Commercial Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualNov 1, 2017 2017
Sold 30,000 shares at $29.25 ($878k)
Tilton John, Chief Commercial Officer
Sold 100% of holdings ($878k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualJan 10, 2019 +435 days
Sold 10,500 shares at $37.67 ($396k)
Tilton John, Chief Commercial Officer
Sold 100% of holdings ($396k position)0 shares leftFiling
- 3 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualMar 12, 2019 +61 days
Sold 10,000 shares at $50.11 ($501k)
Tilton John, Chief Commercial Officer
Sold 100% of holdings ($501k position)0 shares leftFiling
- 4 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualJun 10, 2020 +456 days
Sold 52,000 shares at $67.38 ($3.5M)
Tilton John, Chief Commercial Officer
Sold 98.5% of holdings ($3.6M position)770 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2020 | Jun 12, 2020 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Commercial Officer | Form 4 sale | 52,000 | $3.5M | 98.5% | Unusual | SEC |
| Mar 12, 2019 | Mar 14, 2019 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Commercial Officer | Form 4 sale | 10,000 | $501k | 100.0% | Unusual | SEC |
| Jan 10, 2019 | Jan 14, 2019 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Commercial Officer | Form 4 sale | 10,500 | $396k | 100.0% | Unusual | SEC |
| Nov 1, 2017 | Nov 2, 2017 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Commercial Officer | Form 4 sale | 30,000 | $878k | 100.0% | Unusual | SEC |